A randomized phase II/III trial of rosuvastatin with neoadjuvant chemo-radiation in patients with locally advanced rectal cancer.
Saved in:
| Title: | A randomized phase II/III trial of rosuvastatin with neoadjuvant chemo-radiation in patients with locally advanced rectal cancer. |
|---|---|
| Authors: | Patil PS; Department of Digestive Diseases and Clinical Nutrition, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India., Saklani A; Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India., Kumar NAN; Department of Surgical Oncology, Manipal Comprehensive Cancer Care Center, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, India., De'Souza A; Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India., Krishnatry R; Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India., Khanvilkar S; Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India., Kazi M; Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India., Engineer R; Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India., Ostwal V; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha national Institute, Mumbai, India., Ramaswamy A; Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha national Institute, Mumbai, India., Bal M; Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India., Ranganathan P; Department of Anaesthesiology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India., Gupta E; Laboratory of Chromatin Biology and Epigenetics, Department of Biology, Indian Institute of Science Education and Research, Pune, India.; Centre of Excellence in Epigenetics, Department of Life Sciences, Shiv Nadar Institution of Eminence, Delhi, India., Galande S; Laboratory of Chromatin Biology and Epigenetics, Department of Biology, Indian Institute of Science Education and Research, Pune, India.; Centre of Excellence in Epigenetics, Department of Life Sciences, Shiv Nadar Institution of Eminence, Delhi, India. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Mar 19; Vol. 15, pp. 1450602. Date of Electronic Publication: 2025 Mar 19 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2025.1450602 |
